A Hyperliquid address decreased its Bitcoin short position from 573.759 BTC to 525.806 BTC between two recent snapshots, reducing its exposure by 47.953 BTC, equivalent to about $4.3 million. The value of the short position dropped from $47.4 million to $43.1 million, reflecting a slight decrease in Bitcoin's price from $82,647 to $81,976. This change indicates a strategic adjustment in the short position amid Bitcoin's price fluctuations. Investors may watch for further movements in this address's holdings as a potential indicator of market sentiment.
The Hyperliquid address holding a $43.1 million Bitcoin short position provides context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 16, 2026 18:32 WIB: out of 50 major cryptocurrencies priced on Pluang, 45 rose and 4 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, XTZ at Rp5.745 with a 7.91% gain and 77% sell order activity, and BCH at Rp5.072.791 with a 7.53% rise and 67% sell order activity.
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
